D. Nisato

发表

Conformational preferences and self-association modes of two diastereomeric statine derivatives.

V. Barone, C. Toniolo, F. Fraternali, 2009, International journal of peptide and protein research.

[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.

P. H. van der Graaf, D. Nisato, W. Bax, 1995, European journal of pharmacology.

Oral administration of peptides: Study of a glycerolipidic prodrug

P. Couvreur, D. Nisato, F. Puisieux, 1995 .

Synthesis and in Vitro Study of a Diglyceride Prodrug of a Peptide

P. Couvreur, J. Michel, D. Nisato, 1994, Pharmaceutical Research.

Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.

D. Nisato, P. Fornés, J. Giudicelli, 1999, Cardiovascular research.

Biochemical and Pharmacological Properties of SR 49059 , a New , Potent , Nonpeptide Antagonist of Rat and Human Vasopressin Via Receptors

Ala, C. S. Gal, S., 2022 .

Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats.

G. Vassort, D. Nisato, J. Davy, 2000, The Journal of pharmacology and experimental therapeutics.

Effects of differential blockade of the renin‐angiotensin system in postinfarcted rats

J. Herbert, D. Nisato, C. Roque, 2004, Fundamental & clinical pharmacology.

Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure.

D. Nisato, F. Spinale, D. M. Gay, 2000, The Journal of pharmacology and experimental therapeutics.

Are vasopressin peripheral V1 receptors involved in the development of malignant hypertension and stroke in SHR‐SPs?

D. Nisato, P. Fornés, J. Giudicelli, 1995, Fundamental & clinical pharmacology.

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. S. Gal, J. Maffrand, J. Wagnon, 1993, The Journal of clinical investigation.

Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E‐Deficient Mice

J. Herbert, B. Staels, D. Nisato, 2001, Journal of cardiovascular pharmacology.

Effects of long-term angiotensin II AT receptor blockade on survival , 1 1 hemodynamics and cardiac remodeling in chronic heart failure in rats

D. Nisato, P. Fornés, J. Giudicelli, 1998 .

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. S. Gal, G. Fur, L. Bankir, 1996, The Journal of clinical investigation.

Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction.

D. Nisato, P. Gautier, G. Pastor, 2000, Journal of cardiovascular pharmacology.

Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.

D. Nisato, P. Fornés, M. Gervais, 2000, Journal of cardiovascular pharmacology.

Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.

J. Herbert, D. Nisato, P. Chatelain, 1994, European journal of pharmacology.

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

J. Papp, D. Nisato, L. Virág, 2001, British journal of pharmacology.

Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart.

J. Herbert, D. Nisato, P. Gautier, 2004, European journal of pharmacology.

Use of an antagonist of angiotensin II and a derivative of benzofuran for the preparation of a medicament useful in the treatment of cardiovascular affections

D. Nisato, 1995 .

A potent radiolabeled human renin inhibitor, [3H]SR42128: enzymatic, kinetic, and binding studies to renin and other aspartic proteases.

P. Corvol, D. Nisato, F. Cumin, 1987, Biochemistry.

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.

C. Polidori, R. Ciccocioppo, D. Nisato, 1998, European journal of pharmacology.

Aquaretic and hormonal effects of a vasopressin V(2) receptor antagonist after acute and long-term treatment in rats.

D. Nisato, C. Serradeil-Le Gal, C. Cazaubon, 2000, European journal of pharmacology.

Biochemical and Pharmacological Properties of SR 49059 , a New , Potent , Nonpeptide Antagonist of Rat and HumanVasopressin Via Receptors

G. Guillon, D. Nisato, C. Barberis, 2013 .

Electrophysiological e(cid:128)ects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

J. Papp, D. Nisato, P. Gautier, 2001 .

Study of SR 142801, a new potent non‐peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea‐pig

D. Nisato, A. Roccon, D. Marchionni, 1996, British journal of pharmacology.

Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.

D. Nisato, C. Cazaubon, C. Lacour, 1994, European journal of pharmacology.

Vascular effects of [Arg8]vasopressin in the isolated perfused rat kidney.

D. Nisato, J. Imbs, M. Barthelmebs, 1996, European journal of pharmacology.

Renal vascular reactivity to vasopressin in rats with diabetes mellitus.

D. Nisato, J. Imbs, M. Barthelmebs, 2001, European journal of pharmacology.

In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.

G. Evin, P. Corvol, D. Nisato, 1985, Journal of cardiovascular pharmacology.

Aldehydic peptides inhibiting renin

A. Heitz, J. Fehrentz, D. Nisato, 1984, FEBS letters.

Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity.

E. J. Simon, D. Nisato, A. Tarantino, 1983, Life sciences.

Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats

J. Helwig, D. Nisato, J. Imbs, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development

P. Bruneval, D. Nisato, P. Fornés, 1995, Journal of hypertension.

In Vivo and In Vitro Antiarrhythmic Effects of SSR149744C in Animal Models of Atrial Fibrillation and Ventricular Arrhythmias

J. Herbert, D. Nisato, P. Gautier, 2005, Journal of cardiovascular pharmacology.

Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells.

D. Nisato, E. Guillemare, P. Gautier, 2000, Journal of cardiovascular pharmacology.

Conformational analysis of pepstatin and related renin inhibitors by 400 MHz 1H n.m.r. spectroscopy.

M. Delepierre, B. Roques, J. Wagnon, 2009, International journal of peptide and protein research.

A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.

P. Polster, D. Nisato, D Nisato, 1992, Journal of medicinal chemistry.

Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid

D. Nisato, P. Jouin, B. Castro, 1987 .

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.

G. Griebel, J. Simiand, P. Soubrié, 2002, The Journal of pharmacology and experimental therapeutics.

Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activity

G. Fur, D. Nisato, J. Breliere, 1994 .

HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.

J. Chermann, J. Fehrentz, D. Nisato, 1992, Biochemical and biophysical research communications.

Statine based tripeptides as potent inhibitors of HIV-1 replication.

J. Chermann, J. Fehrentz, D. Nisato, 1992, Biochemical and biophysical research communications.

Stereospecific Synthesis of N‐Protected Statine and Its Analogues via Chiral Tetramic Acid.

D. Nisato, P. Jouin, B. Castro, 1987 .

Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity.

D. Nisato, J. Bali, R. Magous, 1985, Journal of medicinal chemistry.

Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication.

J. Chermann, I. Hirsch, D. Nisato, 1992, Research in virology.

A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan

D. Nisato, R. Reeves, J. Powell, 1998 .

Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart.

D. Cokkinos, D. Nisato, I. Mourouzis, 2002, European journal of pharmacology.

High concentrations of oxytocin cause vasoconstriction by activating vasopressin V1A receptors in the isolated perfused rat kidney

D. Nisato, J. Imbs, M. Barthelmebs, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells

Patrick Gautier, Yves Tourneur, D. Nisato, 2003, Journal of cardiovascular pharmacology.

In Vivo and In Vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-Adrenergic, and Anti-Angiotensin II Effects

Patrick Gautier, J. Herbert, D. Nisato, 2004, Journal of cardiovascular pharmacology.

Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.

D. Nisato, B. Christophe, P. Chatelain, 1995, European journal of pharmacology.

Development of tetrazole bioisosteres in angiotensin II antagonists

G. Fur, D. Nisato, J. Breliere, 1994 .

Abilities of some tryptophan and phenylalanine derivatives to inhibit gastric acid secretion.

D. Nisato, J. Bali, R. Magous, 1985, Biochimica et biophysica acta.

Pharmacological profile of a new peptidic gastrin antagonist

D. Nisato, J. Bali, R. Magous, 1986, Regulatory Peptides.

Reply to the comment on “Effects of long term angiotensin II AT-1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats”

D. Nisato, P. Fornés, J. Giudicelli, 1999 .

Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition.

D. Nisato, J. Imbs, M. Barthelmebs, 2000, Hypertension.

Structural aspects of small peptides. Synthesis and characterization of protected homo‐oligomers derived from L‐alanine

C. Toniolo, G. Bonora, D. Nisato, 1975 .

Effects of SR 142801, the first non-peptide NK3 receptor antagonist on cardiovascular and behavioural responses to senktide in guinea-pigs

D. Nisato, A. Roccon, D. Marchionni, 1995 .

Shear stress modulates vasopressin-induced renal vasoconstriction in rats

J. Helwig, D. Nisato, J. Imbs, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonists

G. Fur, D. Nisato, J. Breliere, 1994 .

Chemical modification of arginine by nitromalondialdehyde. Synthesis and properties of -(5-nitro-2-pyrimidyl) ornithyl derivatives.

G. Bonora, D. Nisato, L. Biondi, 1971, Biochemistry.